Russomanno v. Sunovion Pharmaceuticals Inc. ( 2023 )


Menu:
  • Case: 23-1020   Document: 25     Page: 1   Filed: 02/28/2023
    NOTE: This order is nonprecedential.
    United States Court of Appeals
    for the Federal Circuit
    ______________________
    GINA RUSSOMANNO,
    Plaintiff-Appellant
    v.
    SUNOVION PHARMACEUTICALS INC., IQVIA,
    INC., DAN DUGAN, JENNA YACKISH, TREVOR
    VOLTZ, ERIC WEEDON,
    Defendants-Appellees
    ______________________
    2023-1020, 2023-1022
    ______________________
    Appeals from the United States District Court for the
    District of New Jersey in Nos. 3:19-cv-05945-FLW-DEA,
    and 3:20-cv-12336-FLW-DEA, Judge Freda L. Wolfson.
    ______________________
    ON MOTION
    ______________________
    PER CURIAM.
    ORDER
    In response to this court’s January 3, 2023, order to
    show cause, IQVIA, Inc. urges dismissal of these appeals.
    Gina Russomanno opposes dismissal and moves for sum-
    mary determination.
    Case: 23-1020     Document: 25      Page: 2    Filed: 02/28/2023
    2           RUSSOMANNO    v. SUNOVION PHARMACEUTICALS INC.
    Ms. Russomanno brought these employment-related
    suits against her former private employer. On the motion
    of the defendants, the United States District Court for the
    District of New Jersey dismissed. In September 2022, Ms.
    Russomanno moved to reopen, which the district court de-
    nied on September 27, 2022. Ms. Russomanno then filed
    notices of appeals that were transmitted to both this court
    and the United States Court of Appeals for the Third Cir-
    cuit.
    Ms. Russomanno’s appeals do not fall within the lim-
    ited jurisdiction that Congress granted to this court to re-
    view decisions of federal district courts under 
    28 U.S.C. § 1295
    (a). That jurisdiction extends only to cases arising
    under the patent laws, see 
    28 U.S.C. § 1295
    (a)(1); civil ac-
    tions on review to the district court from the United States
    Patent and Trademark Office, see § 1295(a)(4)(C); or cer-
    tain damages claims against the United States “not exceed-
    ing $10,000 in amount,” 
    28 U.S.C. § 1346
    (a)(2), see 
    28 U.S.C. § 1295
    (a)(2). Ms. Russomanno’s cases are outside of
    that limited review authority.
    While this court may transfer a case under 
    28 U.S.C. § 1631
    , if it is in the interest of justice, to the court where
    “the action or appeal could have been brought at the time
    it was filed,” Ms. Russomanno has already filed an appeal
    with the Third Circuit, which has affirmed the district
    court’s dismissals. Under such circumstances, we see no
    reason to transfer.
    Accordingly,
    IT IS ORDERED THAT:
    (1) The appeals are dismissed.
    (2) All pending motions are denied as moot.
    Case: 23-1020      Document: 25   Page: 3     Filed: 02/28/2023
    RUSSOMANNO     v. SUNOVION PHARMACEUTICALS INC.            3
    (3) Each side shall bear its own costs.
    FOR THE COURT
    February 28, 2023                  /s/ Peter R. Marksteiner
    Date                         Peter R. Marksteiner
    Clerk of Court
    

Document Info

Docket Number: 23-1020

Filed Date: 2/28/2023

Precedential Status: Non-Precedential

Modified Date: 2/28/2023